Company presentation - Mondobiotech

Licensing package
Products ready to enter negotiation for licensing
are accompanied by full product documentation
that interested parties can request.
Documentation includes:
Medicinal Product Candidate
Development Activities
Diseases
Financial Information
IP & Legal
Offered Services
Dossier, API information, Published information.
In vitro activities, Pre-clinical activities, Clinical activities.
Disease dossier, Centers of excellence, Patients associations & other key entities,
Published data, Development plan.
Key competitor, Other market information, Projected sales.
Protection documentation, PCT application, ISR (if available), National applications
(if available): USA, Europe, Australia, Canada, Japan, Singapore, United Arab Emirates,
Korea, Russia. Orphan drug designations/Orphan drug application and granting
(EU/US), EU Regulations, US Regulations, Standard licensing contract and conditions,
Standard service contract.
API, Protocol assistance, Orphan drug & Regulatory assistance, Networking with
Mondobiotech Community (Scientific, Medical, Centers of excellence, Laboratory,
Research organizations and other experts), Scientific & Medical Workshops for developing
and prompting the project, Co-marketing, other development services upon request.
14/33